Vimian Group AB (publ) (STO:VIMIAN)

Sweden · Delayed Price · Currency is SEK

26.50

+0.20 (0.76%)

Feb 10, 2026, 5:29 PM CET

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Specialty Pharma	1.69B
Specialty Pharma Growth	27.99%
MedTech	1.30B
MedTech Growth	20.74%
Veterinary	566.99M
Veterinary Growth	58.65%
Diagnostics	246.14M
Diagnostics Growth	5.15%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	1.43B
United States Growth	18.80%
United Kingdom	434.72M
United Kingdom Growth	32.00%
Other Countries	353.87M
Other Countries Growth	-28.36%
Italy	273.67M
Italy Growth	16.93%
France	220.26M
France Growth	12.59%
Australia	215.14M
Sweden	213.79M
Sweden Growth	100.13%
Denmark	177.53M
Denmark Growth	26.01%
Germany	164.88M
Germany Growth	12.25%
Other	318.87M
Other Growth	372.73%